Gut Microbiota Modulation in the Management of Chronic Obstructive Pulmonary Disease: A Literature Review DOI Open Access

Srihita Patibandla,

Nilay Bhatt,

Sean Lief

и другие.

Cureus, Год журнала: 2024, Номер unknown

Опубликована: Авг. 14, 2024

Chronic obstructive pulmonary disease (COPD) represents a significant global health burden, characterized by progressive airflow limitation and exacerbations that significantly impact patient morbidity mortality. Recent research has investigated the interplay between gut lungs, known as gut-lung axis, highlighting role of microbiome in COPD pathogenesis. Dysbiosis, microbial imbalance, implications for COPD, influencing progression susceptibility to exacerbations. This comprehensive review integrates current scientific literature on microbiota modulation therapeutic avenue management. Through thorough discussion studies investigating probiotics, prebiotics, synbiotics, antibiotics, dietary fiber, fecal transplantation, this summarizes influence these interventions via axis through systemic inflammation, mucosal immunity, metabolic processes. The highlighted here show potential preventing exacerbations, preserving lung function, improving quality life. By compiling latest evidence, provides framework physicians researchers deduce effectiveness an adjunctive strategy

Язык: Английский

The Influence of the Gut Microbiota on Host Health: A Focus on the Gut–Lung Axis and Therapeutic Approaches DOI Creative Commons
Amal S. Alswat

Life, Год журнала: 2024, Номер 14(10), С. 1279 - 1279

Опубликована: Окт. 9, 2024

The human gut microbiota is a complex ecosystem harboring thousands of microbial strains that play crucial role in maintaining the overall well-being its host. composition varies with age from infancy to adulthood and influenced by dietary habits, environment, genetic disposition. Recent advances culture-independent techniques nucleic acid sequencing have improved our understanding diversity microbiota. species present release short-chain fatty acids (SCFAs), which anti-inflammatory properties. also plays substantial modulating host's immune system, promoting tolerance, homeostasis. impact on health host quite evident, as dysbiosis has been linked various diseases, including metabolic disorders, autoimmune allergies, inflammatory bowel diseases. bidirectional communication respiratory creating gut-lung axis, associated different Therapeutic approaches targeting microbiota, such probiotics, prebiotics, interventions, fecal transplantation (FMT), aim restore balance promote growth beneficial gut. Nonetheless, gaining knowledge interactions between necessary develop personalized medicine microbiota-based therapies for conditions. This review summarizes studies related axis particular emphasis Future research directions are discussed.

Язык: Английский

Процитировано

6

The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease DOI Creative Commons

Xiaofan Song,

Xina Dou,

Jiajing Chang

и другие.

Gut Microbes, Год журнала: 2024, Номер 16(1)

Опубликована: Окт. 24, 2024

The current studies have shown that the occurrence and development of chronic obstructive pulmonary disease (COPD) are closely related to changes in gut health its microenvironment, even some diseases significant clinical correlation with COPD. dysbiosis microbiota observed COPD patients also suggests a potential bidirectional interaction between lung. Communication lung may occur through circulating inflammatory cells, microbial metabolites, mediators, but mechanism communication is still under study. Therefore, more research needed this area. In review, we summarize recent animal models on role gut-lung axis mechanisms, so as provide ideas for further field. addition, summarized negative effects medication risk factors proposed prevention treatment strategies.

Язык: Английский

Процитировано

4

Gut Microbiota Modulation in the Management of Chronic Obstructive Pulmonary Disease: A Literature Review DOI Open Access

Srihita Patibandla,

Nilay Bhatt,

Sean Lief

и другие.

Cureus, Год журнала: 2024, Номер unknown

Опубликована: Авг. 14, 2024

Chronic obstructive pulmonary disease (COPD) represents a significant global health burden, characterized by progressive airflow limitation and exacerbations that significantly impact patient morbidity mortality. Recent research has investigated the interplay between gut lungs, known as gut-lung axis, highlighting role of microbiome in COPD pathogenesis. Dysbiosis, microbial imbalance, implications for COPD, influencing progression susceptibility to exacerbations. This comprehensive review integrates current scientific literature on microbiota modulation therapeutic avenue management. Through thorough discussion studies investigating probiotics, prebiotics, synbiotics, antibiotics, dietary fiber, fecal transplantation, this summarizes influence these interventions via axis through systemic inflammation, mucosal immunity, metabolic processes. The highlighted here show potential preventing exacerbations, preserving lung function, improving quality life. By compiling latest evidence, provides framework physicians researchers deduce effectiveness an adjunctive strategy

Язык: Английский

Процитировано

1